{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T04:47:36Z","timestamp":1744174056594},"reference-count":13,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Lymphoma and Myeloma"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.3816\/clm.2008.n.052","type":"journal-article","created":{"date-parts":[[2008,12,9]],"date-time":"2008-12-09T03:09:43Z","timestamp":1228792183000},"page":"356-358","source":"Crossref","is-referenced-by-count":6,"title":["Epstein-Barr Virus\u2014Induced Lymphoproliferative Disorder After Rituximab Combined with CHOP Therapy"],"prefix":"10.3816","volume":"8","author":[{"given":"Anna","family":"Johnston","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gilles","family":"Salles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Espinouse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pascale","family":"Felman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrice","family":"Andr\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7oise","family":"Berger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bertrand","family":"Coiffier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.3816\/CLM.2008.n.052_bib1","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/nrc1452","article-title":"Epstein-Barr virus: 40 years on","volume":"4","author":"Young","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"10.3816\/CLM.2008.n.052_bib2","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1001\/archinte.163.17.1997","article-title":"Posttransplantation lymphoproliferative disorders","volume":"163","author":"Andreone","year":"2003","journal-title":"Arch Intern Med"},{"key":"10.3816\/CLM.2008.n.052_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3960\/jslrt.46.1","article-title":"Senile Epstein-Barr virus-associated B-cell lymphoproliferative disorders: a mini review","volume":"46","author":"Shimoyama","year":"2006","journal-title":"J Clin Exp Hematop"},{"key":"10.3816\/CLM.2008.n.052_bib4","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1097\/00000478-200205000-00009","article-title":"Epstein-Barr virus-positive B-cell lymphoproliferative disorders arising in immunodeficient patients previously treated with fludarabine for low-grade B-cell neoplasms","volume":"26","author":"Abruzzo","year":"2002","journal-title":"Am J Surg Pathol"},{"key":"10.3816\/CLM.2008.n.052_bib5","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.clim.2006.08.009","article-title":"B cell reconstitution after rituximab treatment of lymphoma recapitulates B cell ontogeny","volume":"122","author":"Anolik","year":"2007","journal-title":"Clin Immunol"},{"key":"10.3816\/CLM.2008.n.052_bib6","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1200\/JCO.1998.16.8.2825","article-title":"Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program","volume":"16","author":"McLaughlin","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLM.2008.n.052_bib7","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/sj.bmt.1704742","article-title":"Maintenance rituximab after autologous stem cell transplant for high-risk B-cell lymphoma induces prolonged and severe hypogammaglobulinemia","volume":"35","author":"Lim","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"10.3816\/CLM.2008.n.052_bib8","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1080\/10428190701411441","article-title":"Rituximab-related viral infections in lymphoma patients","volume":"48","author":"Aksoy","year":"2007","journal-title":"Leuk Lymph"},{"key":"10.3816\/CLM.2008.n.052_bib9","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1182\/blood.V99.4.1486","article-title":"Unusual viral infections (progressive multifocal leukoencephalopathy and cytomegalovirus disease) after high-dose chemotherapy with autologous blood stem cell rescue and peritransplantation rituximab","volume":"99","author":"Goldberg","year":"2002","journal-title":"Blood"},{"key":"10.3816\/CLM.2008.n.052_bib10","doi-asserted-by":"crossref","first-page":"e101","DOI":"10.3324\/haematol.11259","article-title":"JC papovavirus leukoencephalopathy after first line treatment with CHOP and rituximab","volume":"92","author":"Rey","year":"2007","journal-title":"Haematologica"},{"key":"10.3816\/CLM.2008.n.052_bib11","doi-asserted-by":"crossref","first-page":"3958","DOI":"10.4049\/jimmunol.168.8.3958","article-title":"Antibody-mediated control of persistent gamma-herpesvirus infection","volume":"168","author":"Kim","year":"2002","journal-title":"J Immunol"},{"key":"10.3816\/CLM.2008.n.052_bib12","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s00277-007-0298-2","article-title":"Rituximab in the management of post-transplantation lymphoproliferative disorder after solid organ transplantation: proceed with caution","volume":"86","author":"Choquet","year":"2007","journal-title":"Ann Hematol"},{"key":"10.3816\/CLM.2008.n.052_bib13","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1111\/j.1365-2141.2006.06482.x","article-title":"Epstein-Barr virus T-cell immunity despite rituximab","volume":"136","author":"Nehring","year":"2007","journal-title":"Br J Haematol"}],"container-title":["Clinical Lymphoma and Myeloma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1557919011702591?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1557919011702591?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,23]],"date-time":"2018-12-23T20:52:57Z","timestamp":1545598377000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1557919011702591"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12]]},"references-count":13,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["S1557919011702591"],"URL":"https:\/\/doi.org\/10.3816\/clm.2008.n.052","relation":{},"ISSN":["1557-9190"],"issn-type":[{"value":"1557-9190","type":"print"}],"subject":[],"published":{"date-parts":[[2008,12]]}}}